The preimplantation genetic testing debate continues: first the hype, then the tension, now the hypertension?
The study by Zhang and colleagues (1) in this month’s Fertility and Sterility asks an important question: Is preimplantation genetic testing (PGT) associated with an increased risk of obstetric complications? Given the physiologic role of the trophectoderm in implantation, invasion, and placentation (2), it seems biologically plausible that manipulation of these cells through biopsy sampling could result in an increased risk of aberrant placentation. The rapid increase in the clinical use of PGT further justifies more scientific inquiry into this question.
Source: fertstert.org
The preimplantation genetic testing debate continues: first the hype, then the tension, now the hypertension?
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection
Be First to Comment